Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University of Munich, Nussbaumstrasse 7, 80336, Munich, Germany.
Eur Arch Psychiatry Clin Neurosci. 2011 Nov;261 Suppl 3:207-45. doi: 10.1007/s00406-011-0259-6.
Current gold standard approaches to the treatment of depression include pharmacotherapeutic and psychotherapeutic interventions with social support. Due to current controversies concerning the efficacy of antidepressants in randomized controlled trials, the generalizability of study findings to wider clinical practice and the increasing importance of socioeconomic considerations, it seems timely to address the uncertainty of concerned patients and relatives, and their treating psychiatrists and general practitioners. We therefore discuss both the efficacy and clinical effectiveness of antidepressants in the treatment of depressive disorders. We explain and clarify useful measures for assessing clinically meaningful antidepressant treatment effects and the types of studies that are useful for addressing uncertainties. This includes considerations of methodological issues in randomized controlled studies, meta-analyses, and effectiveness studies. Furthermore, we summarize the differential efficacy and effectiveness of antidepressants with distinct pharmacodynamic properties, and differences between studies using antidepressants and/or psychotherapy. We also address the differential effectiveness of antidepressant drugs with differing modes of action and in varying subtypes of depressive disorder. After highlighting the clinical usefulness of treatment algorithms and the divergent biological, psychological, and clinical efforts to predict the effectiveness of antidepressant treatments, we conclude that the spectrum of different antidepressant treatments has broadened over the last few decades. The efficacy and clinical effectiveness of antidepressants is statistically significant, clinically relevant, and proven repeatedly. Further optimization of treatment can be helped by clearly structured treatment algorithms and the implementation of psychotherapeutic interventions. Modern individualized antidepressant treatment is in most cases a well-tolerated and efficacious approach to minimize the negative impact of otherwise potentially devastating and life-threatening outcomes in depressive disorders.
目前治疗抑郁症的金标准方法包括药物治疗和心理治疗,并辅以社会支持。由于目前关于抗抑郁药在随机对照试验中的疗效存在争议,研究结果对更广泛的临床实践的普遍性以及社会经济因素的重要性日益增加,因此,似乎及时解决相关患者和家属、他们的精神科医生和全科医生的不确定性是很有必要的。因此,我们讨论了抗抑郁药治疗抑郁障碍的疗效和临床疗效。我们解释和澄清了评估抗抑郁治疗有临床意义的疗效的有用措施,以及解决不确定性的有用研究类型。这包括考虑随机对照研究、荟萃分析和有效性研究中的方法学问题。此外,我们总结了具有不同药效学特性的抗抑郁药的疗效和有效性差异,以及使用抗抑郁药和/或心理治疗的研究之间的差异。我们还讨论了具有不同作用模式和不同抑郁障碍亚型的抗抑郁药物的有效性差异。在强调治疗算法的临床实用性以及预测抗抑郁治疗效果的不同生物学、心理和临床努力的分歧之后,我们得出结论,过去几十年中,不同的抗抑郁治疗方法的范围已经扩大。抗抑郁药的疗效和临床疗效具有统计学意义、临床相关性和反复证明。通过明确的结构化治疗方案和心理治疗干预,可以帮助进一步优化治疗。在大多数情况下,现代个体化抗抑郁治疗是一种耐受良好且有效的方法,可以减轻抑郁障碍中潜在破坏性和危及生命的后果的负面影响。